Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sangro

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Transplantation|February 15, 1997
Partial splenic embolization in the treatment of thrombocytopenia after liver transplantationJ I Herrero, B Sangro, J Quiroga, et al.
Revista Clinica Espanola|April 1, 1989
[Mixed cryoglobulinemia and chronic non-A non-B hepatitis]A Castilla Cortázar, J I Cuende Melero, J Camps Bansell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 19, 2017
Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experienceL Ceniceros, A Chopitea, F Pardo, et al.
Surgery|September 16, 1998
Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institutionB Sangro, M Herráiz, M A Martínez-González, et al.
Cancer Gene Therapy|August 7, 2010
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinomaB Sangro, G Mazzolini, M Ruiz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2012
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinomaM Iñarrairaegui, F Pardo, J I Bilbao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upA Vogel, A Cervantes, I Chau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"A Vogel, A Cervantes, I Chau, et al.
ESMO Open|February 15, 2025
Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL studyD Arnold, P L Pereira, R Iezzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2022
Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]A Vogel, A Cervantes, I Chau, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Transplantation|February 15, 1997
Partial splenic embolization in the treatment of thrombocytopenia after liver transplantationJ I Herrero, B Sangro, J Quiroga, et al.
Revista Clinica Espanola|April 1, 1989
[Mixed cryoglobulinemia and chronic non-A non-B hepatitis]A Castilla Cortázar, J I Cuende Melero, J Camps Bansell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 19, 2017
Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experienceL Ceniceros, A Chopitea, F Pardo, et al.
Surgery|September 16, 1998
Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institutionB Sangro, M Herráiz, M A Martínez-González, et al.
Cancer Gene Therapy|August 7, 2010
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinomaB Sangro, G Mazzolini, M Ruiz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2012
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinomaM Iñarrairaegui, F Pardo, J I Bilbao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upA Vogel, A Cervantes, I Chau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"A Vogel, A Cervantes, I Chau, et al.
ESMO Open|February 15, 2025
Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL studyD Arnold, P L Pereira, R Iezzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2022
Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255]A Vogel, A Cervantes, I Chau, et al.
Pageof 8